The past couple of years have witnessed important and often controversial legal/regulatory developments with direct impact on pharmacy practice. This presentation will address those developments that fall under 2 general categories: (1) federal and state efforts to improve drug information communication with patients; and (2) Drug Enforcement Administration (DEA) efforts to further regulate controlled substances in order to prevent diversion and abuse.
With the overall goal of reducing medication-related adverse events, the FDA and some states have focused on the quality of drug information provided by pharmacies to patients. Particular attention has been directed to 2 areas: The label affixed to the dispensed medication container, and the written patient information provided with the dispensed medication, called “consumer medication information” (CMI). Regarding the label, California has led the way with a regulation requiring standardized, patient-oriented labels on all dispensed prescription drugs.
With the overall goal of reducing medication-related adverse events, the FDA and some states have focused on the quality of drug information provided by pharmacies to patients. Particular attention has been directed to 2 areas: The label affixed to the dispensed medication container, and the written patient information provided with the dispensed medication, called “consumer medication information” (CMI). Regarding the label, California has led the way with a regulation requiring standardized, patient-oriented labels on all dispensed prescription drugs.
Date: Dec 9, 2020 11:00 AM - 12:00 PM
Fee
$0.00
Activity Type
- Knowledge
Accreditation(s)
This CE activity was developed by The Rx Consultant, a publication of Continuing Education Network, Inc.
CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours. CE credit is automatically reported to CPE Monitor.
CE activities for Nurse Practitioners and Clinical Nurse Specialists:
This continuing education activity meets the requirements of:
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
This is a pharmacotherapeutics/pharmacology CE activity.
- The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
- Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.
- Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Objectives
- List the USP Advisory Panel recommendations to improve prescription labels. Discuss the FDA's current views regarding consumer medication information (CMI) and MedGuides.
- Describe the laws and challenges regarding the provision of drug information to limited English proficiency patient
Speaker(s)/Author(s)
|
Alan P. Agins
|
Activity Number
0428-0000-18-024-H01-P
Date:
12/09/20
Time:
11:20 AM - 12:00 PM